https://www.selleckchem.com/pr....oducts/pd0166285.htm
95 (95% CI, 0.93-0.97) in the validation cohort. In addition, the biomarker panel model yielded an AUC of 0.78 (95% CI, 0.74-0.81) for stage I II lung cancer, better than the performance of individual biomarker alone. Conclusions It was demonstrated that 4-protein biomarker panel had a significant performance in identifying lung cancer patients from healthy controls, especially combining with the nodule size. Specifically, it yielded excellent discrimination for identifying early-stage lung cancer patients than individual biomar
Curtir
Comentario
Compartilhar
